These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27153280)

  • 21. Open PHACTS: semantic interoperability for drug discovery.
    Williams AJ; Harland L; Groth P; Pettifer S; Chichester C; Willighagen EL; Evelo CT; Blomberg N; Ecker G; Goble C; Mons B
    Drug Discov Today; 2012 Nov; 17(21-22):1188-98. PubMed ID: 22683805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public-private partnerships for public health.
    Reich MR
    Nat Med; 2000 Jun; 6(6):617-20. PubMed ID: 10835666
    [No Abstract]   [Full Text] [Related]  

  • 23. Public-private partnerships and global health equity: prospects and challlenges.
    Asante AD; Zwi AB
    Indian J Med Ethics; 2007; 4(4):176-80. PubMed ID: 18630239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial lessons from public-private partnerships in drug and vaccine development.
    Wheeler C; Berkley S
    Bull World Health Organ; 2001; 79(8):728-34. PubMed ID: 11545329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.
    Patel AC; Coyle AJ
    Clin Pharmacol Ther; 2013 Sep; 94(3):314-6. PubMed ID: 23645247
    [No Abstract]   [Full Text] [Related]  

  • 26. Implementing a public-private mix model for tuberculosis treatment in urban Pakistan: lessons and experiences.
    Naqvi SA; Naseer M; Kazi A; Pethani A; Naeem I; Zainab S; Fatmi Z
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):817-21. PubMed ID: 22507031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indian biotechnology--rapidly evolving and industry led.
    Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
    [No Abstract]   [Full Text] [Related]  

  • 28. The innovative medicines initiative: a European response to the innovation challenge.
    Goldman M
    Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bailing out.
    Petsko GA
    Genome Biol; 2011 Oct; 12(10):131. PubMed ID: 22035635
    [No Abstract]   [Full Text] [Related]  

  • 30. Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry.
    Zhang Z; Jia M; Wan D
    Int J Health Care Finance Econ; 2009 Jun; 9(2):169-82. PubMed ID: 19360467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare identities at the crossroads of service modernisation: the transfer of NHS clinicians to the independent sector?
    Waring J; Bishop S
    Sociol Health Illn; 2011 Jul; 33(5):661-76. PubMed ID: 21314688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Public-private collaboration in health and human service delivery: evidence from community partnerships.
    Bazzoli GJ; Stein R; Alexander JA; Conrad DA; Sofaer S; Shortell SM
    Milbank Q; 1997; 75(4):533-61. PubMed ID: 9415091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Open-access public-private partnerships to enable drug discovery--new approaches.
    Müller S; Weigelt J
    IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. South Korean biotechnology--a rising industrial and scientific powerhouse.
    Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficiency and productivity changes in large urban hospitals 1994-2002: ownership, markets, and the uninsured.
    Ferrier GD; Valdmanis VG
    Adv Health Econ Health Serv Res; 2008; 18():157-76. PubMed ID: 19725361
    [No Abstract]   [Full Text] [Related]  

  • 36. The emergence of Egyptian biotechnology from generics.
    Abdelgafar B; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680
    [No Abstract]   [Full Text] [Related]  

  • 37. Pierre Meulien.
    Meulien P; Mullard A
    Nat Rev Drug Discov; 2015 Aug; 14(8):521. PubMed ID: 26228752
    [No Abstract]   [Full Text] [Related]  

  • 38. Global strategic partnerships in regenerative medicine.
    French A; Suh JY; Suh CY; Rubin L; Barker R; Bure K; Reeve B; Brindley DA
    Trends Biotechnol; 2014 Sep; 32(9):436-40. PubMed ID: 25150363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Public-private partnerships. Going into labour.
    Lissauer R
    Health Serv J; 2001 Jun; 111(5761):24-5. PubMed ID: 11458560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outsourcing discovery.
    Mallapaty S
    Nature; 2017 Dec; 552(7683):S5. PubMed ID: 29219992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.